These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 9124211)
1. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype. Alsabeh R; Brynes RK; Slovak ML; Arber DA Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211 [TBL] [Abstract][Full Text] [Related]
2. Acute myelogenous leukemia with t(6;9)(p23;q34) and marrow basophilia: an overview. Chi Y; Lindgren V; Quigley S; Gaitonde S Arch Pathol Lab Med; 2008 Nov; 132(11):1835-7. PubMed ID: 18976025 [TBL] [Abstract][Full Text] [Related]
3. Enhanced myeloid specificity of CD117 compared with CD13 and CD33. Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319 [TBL] [Abstract][Full Text] [Related]
4. [A clinical and laboratory study on acute myeloid leukemia with t(6;9)(p23;q34)]. Wang Y; Xue Y; Chen S; Wu Y; Pan J; Zhang J; Shen J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):34-7. PubMed ID: 20140864 [TBL] [Abstract][Full Text] [Related]
5. Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature. Lillington DM; MacCallum PK; Lister TA; Gibbons B Leukemia; 1993 Apr; 7(4):527-31. PubMed ID: 8464230 [TBL] [Abstract][Full Text] [Related]
6. Trisomy 11: an association with stem/progenitor cell immunophenotype. Slovak ML; Traweek ST; Willman CL; Head DR; Kopecky KJ; Magenis RE; Appelbaum FR; Forman SJ Br J Haematol; 1995 Jun; 90(2):266-73. PubMed ID: 7794746 [TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Oyarzo MP; Lin P; Glassman A; Bueso-Ramos CE; Luthra R; Medeiros LJ Am J Clin Pathol; 2004 Sep; 122(3):348-58. PubMed ID: 15362364 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34). Visconte V; Shetty S; Przychodzen B; Hirsch C; Bodo J; Maciejewski JP; Hsi ED; Rogers HJ Int J Lab Hematol; 2017 Aug; 39(4):409-417. PubMed ID: 28318095 [TBL] [Abstract][Full Text] [Related]
12. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894 [TBL] [Abstract][Full Text] [Related]
13. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias. Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000 [TBL] [Abstract][Full Text] [Related]
14. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia. Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796 [TBL] [Abstract][Full Text] [Related]
15. [Acute myeloblastic leukemia without maturation (AML-M1) with basophilic elements and associated with translocation t(6;9)]. Dimicoli S; Fohlen-Walter A; Mansuy L; Buisine J; Grégoire MJ; Lecompte T; Bordigoni P; Jonveaux P; Lesesve JF Ann Biol Clin (Paris); 2003; 61(3):352-7. PubMed ID: 12805015 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience. Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638 [TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365 [TBL] [Abstract][Full Text] [Related]
18. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [TBL] [Abstract][Full Text] [Related]
19. High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Baer MR; Stewart CC; Dodge RK; Leget G; Sulé N; Mrózek K; Schiffer CA; Powell BL; Kolitz JE; Moore JO; Stone RM; Davey FR; Carroll AJ; Larson RA; Bloomfield CD Blood; 2001 Jun; 97(11):3574-80. PubMed ID: 11369653 [TBL] [Abstract][Full Text] [Related]
20. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes. Xie W; Wang X; Du W; Liu W; Qin X; Huang S Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]